FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC (ANDA 077824).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcers
• Erosive Esophagitis
• Gastric Ulcers
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease

Drugs mentioned

• Ranitidine (Ranitidine)

Snippet

SUPPL AP for RANITIDINE (RANITIDINE)